Fábio Bom Aggio

626 citations
20 papers · 365 indexed · h-index 11

Fábio Bom Aggio

20 papers receiving 344 citations

Peers

Fábio Bom Aggio
Comparison fields: 5 of 49
  • Ophthalmology 329
  • Radiology, Nuclear Medicine and Imaging 149
  • Neurology 26
  • Pharmaceutical Science 9
  • Microbiology 9
Replace Samer Elsherbiny with:
Samer Elsherbiny United Kingdom
Kerstin Wickström Sweden
Bram van Kooij Netherlands
Brandon Wong United States
Brian Flowers United States
Connie Chou United States
Vesna Jakšić Serbia
Erkan Çelik Türkiye
Sayime Aydın Türkiye
Emmett F. Carpel United States
Fábio Bom Aggio relative to Samer Elsherbiny United Kingdom Samer Elsherbiny's profile →
Citations per field
00.5×1.5×1.8×
Samer Elsherbiny · 1×
Citations per year

Countries citing papers authored by Fábio Bom Aggio

Since Specialization
Citations

This map shows the geographic impact of Fábio Bom Aggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fábio Bom Aggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fábio Bom Aggio more than expected).

Fields of papers citing papers by Fábio Bom Aggio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fábio Bom Aggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fábio Bom Aggio. The network helps show where Fábio Bom Aggio may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fábio Bom Aggio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fábio Bom Aggio Line = papers co-authored together Fábio Bom Aggio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20192
2 201710
3 201718
4 20165
5 201526
6 201124
7 20119
8 201031
9 200932
10 20082
11 20081
12 200734
13 200710
14 200760
15 20074
16 20061
17 200635
18 200522
19 200419
20 200420

About Fábio Bom Aggio

Fábio Bom Aggio is a scholar working on Ophthalmology, Parasitology and Clinical Biochemistry, having authored 20 papers that have together received 365 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Retinal and Optic Conditions (9 papers), Ocular Diseases and Behçet’s Syndrome (8 papers), Intraocular Surgery and Lenses (5 papers), Glaucoma and retinal disorders (5 papers), Ocular Infections and Treatments (3 papers), Retinal and Macular Surgery (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Ophthalmology (329 citations), Radiology, Nuclear Medicine and Imaging (149 citations) and Neurology (26 citations). Fábio Bom Aggio has collaborated with scholars based in Brazil. Frequent co-authors include Michel Eid Farah, Gustavo Barreto Melo, Ana Luísa Höfling-Lima, Fernando M. Penha, Acácio Alves de Souza Lima Filho, Maurício Maia, J.A. Cardillo, Daniel Lavinsky, Rubens Belfort and Rubens Belfort Neto. Their work appears in journals such as Graefe s Archive for Clinical and Experimental Ophthalmology, Retina, British Journal of Ophthalmology, Eye and Developments in ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026